Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden

Testosterone replacement therapy (TRT) has been recommended for the treatment of primary and secondary hypogonadism. However, long-term implications of TRT have not been investigated extensively. The aim of this analysis was to evaluate health outcomes and costs associated with life-long TRT in pati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of sexual medicine Jg. 11; H. 1; S. 262
Hauptverfasser:	Arver, Stefan, Luong, Ba, Fraschke, Anina, Ghatnekar, Ola, Stanisic, Sanja, Gultyev, Dmitry, Müller, Elvira
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands 01.01.2014
Schlagworte:	Cardiovascular Diseases - chemically induced Cerebrovascular Disorders - chemically induced Cost-Benefit Analysis Depression - chemically induced Diabetes Mellitus, Type 2 - chemically induced Hormone Replacement Therapy - adverse effects Hormone Replacement Therapy - economics Humans Hypogonadism - drug therapy Klinefelter Syndrome - drug therapy Male Outcome Assessment (Health Care) Quality-Adjusted Life Years Sweden Testosterone - adverse effects Testosterone - economics Testosterone - therapeutic use Sweden Testosterone Replacement Therapy Cost-Effectiveness Long-Term Implications Hypogonadism
ISSN:	1743-6109, 1743-6109
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!